Emisphere Technologies, Inc. (PN) Stock Price - EMIS

Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 7.90 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Emisphere Technologies, Inc. (PN) EMIS OTC BB Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.335 4.43% 7.90 8.24 7.60 7.72 7.565 17:00:14
Bid Price Ask Price Spread Spread % News
7.71 0.00 0.19 2.41% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
203 195,126 $ 7.8927 $ 1,540,075 88,889 2.05 - 11.23
Last Trade Time Type Quantity Stock Price Currency
16:00:21 formt 4,290 $ 7.90 USD

Emisphere Technologies, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 663.70M 84.01M $ -20.94M - - 46.14M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Emisphere Technologies, Inc. (PN) News

Real-Time news about Emisphere Technologies, Inc. (PN) (OTCBB): 0 recent articles

Latest EMIS Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical EMIS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.89488.246.89487.3779,8661.0114.58%
1 Month5.428.245.056.9163,8952.4845.76%
3 Months6.158.243.885.9777,5211.7528.46%
6 Months9.45511.233.887.6685,921-1.56-16.45%
1 Year2.4011.232.057.1594,9875.50229.17%
3 Years0.50111.230.153.8774,4997.401,476.85%
5 Years0.300511.230.152.7668,5217.602,528.95%

Emisphere Technologies, Inc. (PN) Description

Emisphere is a specialty pharmaceutical company that has recently commenced commercial operations. The Company launched its first prescription product, oral Eligen B12, in the U.S. in March 2015. Beyond Eligen B12, the Company utilizes its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere is currently partnered with global pharmaceutical companies for the development of new orally delivered therapeutics. For more information, please visit www.emisphere.com.
Your Recent History
Emisphere ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200118 09:45:56